Nextcure to host virtual r&d update event on march 4, 2021

Beltsville, md., feb. 26, 2021 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will host a virtual r&d update event at 5:00 p.m. et on thursday, march 4.

NXTC Ratings Summary

NXTC Quant Ranking